Charles Schwab’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-21,090
| Closed | -$14K | – | 3535 |
|
|
2020
Q4 | $14K | Hold |
21,090
| – | – | ﹤0.01% | 3387 |
|
|
2020
Q3 | $12K | Hold |
21,090
| – | – | ﹤0.01% | 3331 |
|
|
2020
Q2 | $15K | Hold |
21,090
| – | – | ﹤0.01% | 3307 |
|
|
2020
Q1 | $16K | Hold |
21,090
| – | – | ﹤0.01% | 3206 |
|
|
2019
Q4 | $32K | Hold |
21,090
| – | – | ﹤0.01% | 3146 |
|
|
2019
Q3 | $32K | Hold |
21,090
| – | – | ﹤0.01% | 3142 |
|
|
2019
Q2 | $28K | Sell |
21,090
-94,530
| -82% | -$174K | ﹤0.01% | 3189 |
|
|
2019
Q1 | $302K | Buy |
115,620
+21,090
| +22% | +$49.5K | ﹤0.01% | 2939 |
|
|
2018
Q4 | $156K | Buy |
94,530
+38,330
| +68% | +$108K | ﹤0.01% | 3048 |
|
|
2018
Q3 | $273K | Hold |
56,200
| – | – | ﹤0.01% | 3023 |
|
|
2018
Q2 | $352K | Buy |
56,200
+12,500
| +29% | +$93.2K | ﹤0.01% | 2910 |
|
|
2018
Q1 | $363K | Hold |
43,700
| – | – | ﹤0.01% | 2822 |
|
|
2017
Q4 | $446K | Hold |
43,700
| – | – | ﹤0.01% | 2750 |
|
|
2017
Q3 | $400K | Hold |
43,700
| – | – | ﹤0.01% | 2781 |
|
|
2017
Q2 | $320K | Buy |
43,700
+22,200
| +103% | +$168K | ﹤0.01% | 2840 |
|
|
2017
Q1 | $155K | Hold |
21,500
| – | – | ﹤0.01% | 2967 |
|
|
2016
Q4 | $126K | Hold |
21,500
| – | – | ﹤0.01% | 3026 |
|
|
2016
Q3 | $142K | Hold |
21,500
| – | – | ﹤0.01% | 2980 |
|
|
2016
Q2 | $200K | Buy |
+21,500
| New | +$205K | ﹤0.01% | 2942 |
|
Charles Schwab's NEOS Position: Q1 2021 in Review
Charles Schwab sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 21,090 shares — an estimated $14K sold.
Charles Schwab first reported a position in NEOS in Q2 2016 and held it in 19 quarters. The position peaked at $446K in Q4 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- Charles Schwab reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- Charles Schwab sold 21,090 Neos Therapeutics, Inc shares in Q1 2021, an estimated $14K.
- Charles Schwab first reported a position in Neos Therapeutics, Inc in Q2 2016 and held it in 19 quarters.
- Charles Schwab's Neos Therapeutics, Inc position peaked at $446K in Q4 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.